As of 2026-03-24, the EV/EBITDA ratio of Surgery Partners Inc (SGRY) is -30.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SGRY's latest enterprise value is 5,011.79 mil USD. SGRY's TTM EBITDA according to its financial statements is -166.00 mil USD. Dividing these 2 quantities gives us the above SGRY EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 12.4x | 9.6x |
| Forward P/E multiples | 8.1x - 10.8x | 9.5x |
| Fair Price | (34.39) - 12.58 | (15.66) |
| Upside | -387.1% - 5.0% | -230.7% |
| Date | EV/EBITDA |
| 2026-03-23 | -30.19 |
| 2026-03-20 | -30.05 |
| 2026-03-19 | -30.25 |
| 2026-03-18 | -30.49 |
| 2026-03-17 | -30.71 |
| 2026-03-16 | -30.51 |
| 2026-03-13 | -30.50 |
| 2026-03-12 | -30.78 |
| 2026-03-11 | -31.36 |
| 2026-03-10 | -30.95 |
| 2026-03-09 | -31.22 |
| 2026-03-06 | -31.27 |
| 2026-03-05 | -31.85 |
| 2026-03-04 | -31.83 |
| 2026-03-03 | -31.70 |
| 2026-03-02 | -33.23 |
| 2026-02-27 | -32.93 |
| 2026-02-26 | -32.83 |
| 2026-02-25 | -32.93 |
| 2026-02-24 | -32.84 |
| 2026-02-23 | -32.93 |
| 2026-02-20 | -32.97 |
| 2026-02-19 | -32.82 |
| 2026-02-18 | -33.32 |
| 2026-02-17 | -33.01 |
| 2026-02-13 | -32.90 |
| 2026-02-12 | -32.93 |
| 2026-02-11 | -32.54 |
| 2026-02-10 | -31.71 |
| 2026-02-09 | -31.36 |
| 2026-02-06 | -31.42 |
| 2026-02-05 | -31.32 |
| 2026-02-04 | -31.80 |
| 2026-02-03 | -31.94 |
| 2026-02-02 | -32.39 |
| 2026-01-30 | -32.44 |
| 2026-01-29 | -32.14 |
| 2026-01-28 | -32.43 |
| 2026-01-27 | -32.78 |
| 2026-01-26 | -33.48 |
| 2026-01-23 | -33.43 |
| 2026-01-22 | -33.17 |
| 2026-01-21 | -32.91 |
| 2026-01-20 | -33.04 |
| 2026-01-16 | -33.25 |
| 2026-01-15 | -33.32 |
| 2026-01-14 | -32.86 |
| 2026-01-13 | -33.39 |
| 2026-01-12 | -33.54 |
| 2026-01-09 | -33.42 |